Clinical Study
Randomized, Double-Blind, and Placebo-Controlled Trial of Clenbuterol in Denervated Muscle Atrophy
Table 2
Changes of fibrillation potential amplitudes and muscle fibers following treatments.
| | Clenbuterol | Placebo | |
| Decrease in cross-sectional areas of type I fibers, μm2 | 413 ± 91.7 | 687.1 ± 84.6 | | Decrease in cross-sectional areas of type II fibers, μm2 | 512.1 ± 75.1 | 821.3 ± 118.7 | | Reduction in fibrillation potential amplitude, μV | 57.3 ± 32.7 | 231.5 ± 56.6 | |
|
|
Figures are means ± standard errors.
|